Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Great Basin Scientific Inc.

Latest From North American Vaccine Inc.

Intra-Cellular Therapies Inc.

Built on technology from the lab of Nobel laureate Paul Greengard, PhD, Intra-Cellular Therapies Inc. aims to develop small-molecule compounds that modify intracellular responses to endogenous neurotransmitters as therapeutics for Parkinson's disease, depression, schizophrenia and other CNS disorders.
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Great Basin Corp.
  • Great Basin Scientific Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Great Basin Scientific Inc.
  • Senior Management
  • Ryan Ashton, Pres. & CEO
    Jeffrey Rona, CFO
    Robert D Jenison , CTO
    Sandra Nielsen, SVP, Sales & Mktg.
    Wesley C Lindsey, PhD, Dir., Product Dev.
    Walter Hammond, VP, Mfg
    Carlos B Gonzalez, VP, Engineering
  • Contact Info
  • Great Basin Scientific Inc.
    Phone: (801) 990-1055
    2441 South 3850 West
    Salt Lake City, UT 84120